Moderna's CEO predicts how the biotech's work in cancer vaccines could transform healthcare, starting with your annual physicalBusiness Insider • 12/14/22
Moderna rockets higher as vaccine offers glimpse of 'new paradigm ' in cancer treatmentProactive Investors • 12/14/22
Moderna Soars On Cancer Vaccine News: Here's What To Watch Going Forward - Moderna (NASDAQ:MRNA)Benzinga • 12/13/22
Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough in how we treat the diseaseBusiness Insider • 12/13/22
Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trialBusiness Insider • 12/13/22
Is Moderna Stock A Buy On A Bullish Update For Its Cancer Vaccine?Investors Business Daily • 12/13/22
Merck, Moderna say mRNA vaccine and Keytruda lowers the risk of death in melanoma patientsMarket Watch • 12/13/22
Why Merck's $250 Million Investment In Moderna May Have Just Paid OffInvestors Business Daily • 12/13/22
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA(R) (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 TrialAccesswire • 12/13/22
PFIZER VS MODERNA; Which Pharmaceutical Is A Better Stock To Buy Now?The Dog of Wall Street • 12/10/22